Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations.
Ferrari A, Cangini D, Ghelli Luserna di Rorà A, Condorelli A, Pugliese M, Schininà G, Cosentino S, Fonzi E, Domizio C, Simonetti G, Leotta S, Milone G, Martinelli G. Ferrari A, et al. Among authors: martinelli g. Front Cell Dev Biol. 2023 May 23;11:1165308. doi: 10.3389/fcell.2023.1165308. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37287455 Free PMC article.
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Ghetti M, Vannini I, Bochicchio MT, Azzali I, Ledda L, Marconi G, Melloni M, Fabbri F, Rondoni M, Chicchi R, Angeli D, Ghelli Luserna di Rorà A, Giannini B, Zacheo I, Biguzzi R, Lanza F, Martinelli G, Simonetti G. Ghetti M, et al. Among authors: martinelli g. Biomed Pharmacother. 2023 Sep;165:115235. doi: 10.1016/j.biopha.2023.115235. Epub 2023 Aug 1. Biomed Pharmacother. 2023. PMID: 37536029 Free article.
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Di Rorà AGL, Ghetti M, Ledda L, Ferrari A, Bocconcelli M, Padella A, Napolitano R, Fontana MC, Liverani C, Imbrogno E, Bochicchio MT, Paganelli M, Robustelli V, Sanogo S, Cerchione C, Fumagalli M, Rondoni M, Imovilli A, Musuraca G, Martinelli G, Simonetti G. Di Rorà AGL, et al. Among authors: martinelli g. Cell Biol Toxicol. 2024 Aug 31;40(1):73. doi: 10.1007/s10565-024-09913-1. Cell Biol Toxicol. 2024. PMID: 39215871 Free PMC article. No abstract available.
Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.
Ghelli Luserna di Rorà A, Jandoubi M, Padella A, Ferrari A, Marranci A, Mazzotti C, Olimpico F, Ghetti M, Ledda L, Bochicchio MT, Paganelli M, Zanoni M, Cafaro A, Servili C, Galimberti S, Gottardi M, Rondoni M, Endri M, Onofrillo D, Audisio E, Marconi G, Simonetti G, Martinelli G. Ghelli Luserna di Rorà A, et al. Among authors: martinelli g. J Transl Med. 2024 Nov 26;22(1):1062. doi: 10.1186/s12967-024-05838-9. J Transl Med. 2024. PMID: 39587643 Free PMC article.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R. Bassan R, et al. Among authors: martinelli g. Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596. Blood Adv. 2023. PMID: 37276451 Free PMC article.
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia.
Mosquera Orgueira A, Peleteiro Raíndo A, Díaz Arias JÁ, Antelo Rodríguez B, López Riñón M, Cerchione C, de la Fuente Burguera A, González Pérez MS, Martinelli G, Montesinos Fernández P, Pérez Encinas MM. Mosquera Orgueira A, et al. Among authors: martinelli g. Front Oncol. 2023 Oct 4;13:1302993. doi: 10.3389/fonc.2023.1302993. eCollection 2023. Front Oncol. 2023. PMID: 37860185 Free PMC article.
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Konopleva MY, Dail M, Daver NG, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, Pollyea DA, Tafuri A, Brandwein JM, Pigneux A, Powell BL, Fenaux P, Olin RL, Visani G, Martinelli G, Onishi M, Wang J, Huang W, Dunshee DR, Hamidi H, Ott MG, Hong WJ, Andreeff M. Konopleva MY, et al. Among authors: martinelli g. Clin Lymphoma Myeloma Leuk. 2024 Jun;24(6):364-374. doi: 10.1016/j.clml.2024.01.007. Epub 2024 Jan 18. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38378362 Free article. Clinical Trial.
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice.
Messina M, Piciocchi A, Siena LM, Soddu S, Buccisano F, Mecucci C, Martinelli G, Curti A, Cairoli R, Fazi P, Vignetti M, Voso MT, Venditti A, Candoni A. Messina M, et al. Among authors: martinelli g. EJHaem. 2024 Nov 22;5(6):1274-1277. doi: 10.1002/jha2.1045. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691247 Free PMC article.
1,469 results